mebendazole has been researched along with Multiple Myeloma in 3 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Luber, V | 1 |
| Lutz, M | 1 |
| Abele-Horn, M | 1 |
| Einsele, H | 1 |
| Grigoleit, GU | 1 |
| Mielke, S | 1 |
| Chen, XH | 1 |
| Xu, YJ | 1 |
| Wang, XG | 1 |
| Lin, P | 1 |
| Cao, BY | 1 |
| Zeng, YY | 1 |
| Wang, Q | 1 |
| Zhang, ZB | 1 |
| Mao, XL | 1 |
| Zhang, T | 1 |
| Spagnuolo, PA | 1 |
| Hu, J | 1 |
| Hurren, R | 1 |
| Wang, X | 1 |
| Gronda, M | 1 |
| Sukhai, MA | 1 |
| Di Meo, A | 1 |
| Boss, J | 1 |
| Ashali, I | 1 |
| Beheshti Zavareh, R | 1 |
| Fine, N | 1 |
| Simpson, CD | 1 |
| Sharmeen, S | 1 |
| Rottapel, R | 1 |
| Schimmer, AD | 1 |
3 other studies available for mebendazole and Multiple Myeloma
| Article | Year |
|---|---|
Excretion of Ascaris lumbricoides following reduced-intensity allogeneic hematopoietic stem cell transplantation and consecutive treatment with mebendazole.
Topics: Animals; Ascariasis; Ascaris lumbricoides; Egypt; Feces; Hematopoietic Stem Cell Transplantation; Hu | 2020 |
Mebendazole elicits potent antimyeloma activity by inhibiting the USP5/c-Maf axis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cyanoacrylates; Drug Repositioning; Dru | 2019 |
The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma.
Topics: Animals; Antinematodal Agents; Antineoplastic Agents, Phytogenic; Cell Death; Cell Survival; Dose-Re | 2010 |